Koyfin Home > Directory > Health Care > Adma Biologics > Debt Issued

Adma Biologics Debt Issued Chart (ADMA)

Adma Biologics annual/quarterly Debt Issued from 2010 to 2020.
  • Adma Biologics Debt Issued for the quarter ending September 09, 2020 was $0m a 0.00% decrease of 0m year over year
  • Adma Biologics Debt Issued for the last 12 months ending September 09, 2020 was $13m a -480.00% decrease of -60m year over year
  • Adma Biologics Annual Debt Issued for 2019 was $73m a 37.93% increase of 28m from 2018
  • Adma Biologics Annual Debt Issued for 2017 was $45m a 91.11% increase of 41m from 2016
  • Adma Biologics Annual Debt Issued for 2016 was $4m a -300.00% decrease of -12m from 2015
Other Cash Flow Metrics:
  • Adma Biologics Cash Flow from Operations for the quarter ending December 12, 2018 was $-19m a 12.55% decrease of -2m year over year
  • Adma Biologics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-14m a 28.03% decrease of -4m year over year
  • Adma Biologics Total Revenue for the quarter ending September 09, 2018 was $4m a -183.74% decrease of -8m year over year
View Chart On Koyfin

Quarterly ADMA Debt Issued Data

09/2020$0m
06/2020$0m
03/2020$13m
12/2019$0m
09/2019$0m
06/2019$28m
03/2019$45m
12/2017$30m
09/2017$0m
06/2017$15m

Annual ADMA Debt Issued Data

2019$73m
2017$45m
2016$4m
2015$16m
2014$10m
2013$1m
2012$4m
2011$2m
2010$2m